Mohamed Abazeed, Professor and Chair of Radiation Oncology at Northwestern Medicine, shared a post on LinkedIn:
“An exciting advance from our colleagues at Northwestern Medicine.
Published today in JAMA, this study demonstrates that, in carefully selected patients with treatment-refractory, lung-limited non-small cell lung cancer, lung transplantation can improve survival, challenging long-held assumptions about what is possible for advanced lung cancer.
Congratulations to the outstanding multidisciplinary team whose vision and collaboration made this landmark work possible. I’m grateful to work alongside colleagues who continue to expand what’s possible for our patients through innovation and collaboration.”
Title: Lung Transplant for Refractory Lung-Limited Stage IV Non–Small Cell Lung Cancer
Authors: Ankit Bharat, Chitaru Kurihara, Liam IL-Young Chung, Ruli Gao, Samuel Kim, Kalvin Lung, Catherine Myers, Mrinalini Venkata Subramani, Momen Wahidi, Mohamed E. Abazeed, Brooke Sanson, Ronald Min, Tarik Demir, Sang Hwa Kim, Chan Mi Jung, Yuchan Kim, Ambalavanan Arunachalam, Masha Kocherginsky, G. R. Scott Budinger, Young Kwang Chae
Other articles featuring Mohamed Abazeed on OncoDaily.